6505--PET Radiopharmaceuticals for Nuclear Medicine Department at the Buffalo VA Medical Center
ID: 36C24225Q0334Type: Combined Synopsis/Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF242-NETWORK CONTRACT OFFICE 02 (36C242)ALBANY, NY, 12208, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/837b0193e23d45c3849ef7a8a74aff94/view
Timeline
    Description

    The Department of Veterans Affairs is seeking proposals for the procurement of Positron Emission Tomography (PET) Radiopharmaceuticals for the Nuclear Medicine Department at the Buffalo VA Medical Center. This combined synopsis/solicitation aims to acquire various radiopharmaceuticals, including FDG, Cu64, F18-DCFPyl PSMA, Ga-68 DOTATATE, and F18 Florbetaben, under an Indefinite Delivery, Indefinite Quantity (IDIQ) contract structure with a performance period from April 15, 2025, to April 14, 2028. These radiopharmaceuticals are critical for enhancing healthcare services provided to veterans, ensuring they receive reliable access to essential medical supplies. Interested vendors must submit their quotes by March 28, 2025, at 4:00 PM Eastern Time, and can contact Contracting Officer Jonathan Kilgore at jonathan.kilgore@va.gov or 973-676-1000 for further inquiries.

    Point(s) of Contact
    Jonathan KilgoreContracting Officer
    (973) 676-1000
    jonathan.kilgore@va.gov
    Files
    Title
    Posted
    36C24225Q0334_1.docx
    The document outlines a combined synopsis and solicitation notice for PET Radiopharmaceuticals required by the Buffalo VA Medical Center, with the purpose of seeking proposals from suppliers. The document specifies the contracting office, important dates, and details necessary for submission, including the response deadline of March 28, 2025, at 4:00 PM Eastern Time. The solicitation falls under the Product Service Code 6505 and the NAICS Code 325412. The primary contact for inquiries is Contracting Officer Jonathan Kilgore, whose contact information is provided. Interested parties are directed to the agency's website for further details. It emphasizes the need for PET Radiopharmaceuticals, integral to the medical services provided to veterans. All proposals must adhere to the guidelines mentioned in the detailed solicitation document attached to the notice. This solicitation reflects the government's ongoing commitment to procure essential medical supplies to enhance healthcare for veterans.
    S02 - Combined Synopsis Solicitation - PET Radiopharmaceutical.docx
    The Network Contracting Office 02 is issuing a Combined Synopsis/Solicitation for the acquisition of Positron Emission Tomography (PET) Radiopharmaceuticals for the Nuclear Medicine Department at the Buffalo VA Medical Center. The procurement is based on full and open competition under NAICS code 325412, with a small business size standard of 1,300 employees. The contract will be an Indefinite Delivery, Indefinite Quantity (IDIQ) with a performance period from April 15, 2025, to April 14, 2028, including two option years. Vendors are required to quote inclusive prices covering all costs, including shipping and handling. The solicitation outlines specific radiopharmaceuticals needed, their estimated annual usage, and detailed requirements for delivery, including packaging and quality control standards as mandated by regulatory agencies. The awarded contractor must be licensed by the Nuclear Regulatory Commission and provide assurances of compliance with all federal and state regulations. Proposals will be evaluated based on technical capability, past performance, and price, ensuring comprehensive assessment to select the most favorable offer for the government. The deadline for submission of quotes is March 28, 2025.
    S02 - Combined Synopsis Solicitation - PET Radiopharmaceutical.pdf
    The document is a combined synopsis/solicitation for the procurement of commercial radiopharmaceuticals for the Nuclear Medicine Department at the Buffalo VA Medical Center. It outlines the requirements and procedures for interested vendors to submit quotes for various radiopharmaceuticals, including FDG, Cu64, F18-DCFPyl PSMA, Ga-68 DOTATATE, and F18 Florbetaben. The contract is structured as an Indefinite Delivery, Indefinite Quantity (IDIQ) with a three-year term starting April 15, 2025, allowing for full and open competition under NAICS code 325412. Quotes should be all-inclusive, covering shipping and handling, with a guaranteed minimum value of $100,000. Vendors must comply with FDA and NRC regulations and demonstrate their capacity to maintain quality control and safety throughout the contract period. The evaluation criteria for award selection include technical capability, past performance, and price, with an emphasis on compliance with federal standards for handling radioactive materials. The solicitation includes detailed instructions for submission and a deadline for responses. Overall, the document serves as a formal request for proposals aimed at enhancing healthcare services for veterans through reliable access to essential radiopharmaceuticals.
    Lifecycle
    Title
    Type
    6505--PET Radiopharmaceuticals for Nuclear Medicine Department at the Buffalo VA Medical Center
    Currently viewing
    Combined Synopsis/Solicitation
    Similar Opportunities
    6505--Radiopharmaceuticals For The Portland VA Medical Center
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the procurement of radiopharmaceuticals for the Portland VA Medical Center. This opportunity, identified by solicitation number 36C26025Q0237, aims to establish a five-year Indefinite Delivery Indefinite Quantity (IDIQ) contract to supply essential nuclear medicine supplies, ensuring 24/7 availability and prompt delivery for patient care. The procurement is particularly significant as it supports the medical needs of veterans while promoting participation from Service-Disabled Veteran-Owned Small Businesses (SDVOSB). Interested vendors must submit their proposals by March 28, 2025, at 13:00 Pacific Time, and can direct inquiries to José Ronstadt at jose.ronstadt@va.gov or by phone at 360-852-9885.
    6505--Radiopharmaceutical Isotopes (Cardiology)
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the procurement of radiopharmaceutical isotopes for the Nuclear Cardiology lab at the William S. Middleton Memorial Veterans Hospital in Madison, Wisconsin. The contract will cover the mixing, dispensing, and delivery of various isotopes, including 99mTc-Tetrofosmin and 67Ga-Gallium Citrate, which are essential for diagnostic testing and quality assurance in cardiac procedures. This initiative underscores the VA's commitment to providing high-quality medical services to veterans while ensuring compliance with federal safety regulations in nuclear medicine practices. Interested vendors must submit their quotations by 5:00 PM on March 20, 2025, to the Contracting Officer, Stacy Massey, at Stacy.Massey@va.gov.
    W065--Mobile Digital PET/CT Trailer
    Buyer not available
    The Department of Veterans Affairs is seeking information from qualified vendors for the leasing of a mobile digital positron emission tomography (PET)/computed tomography (CT) scanner for the Clement J. Zablocki VA Medical Center in Milwaukee, Wisconsin. The procurement aims to identify sources capable of providing a fully equipped mobile scanner that meets specific operational criteria for oncology and other imaging purposes, including features such as handicapped accessibility, an intercom system, and advanced imaging capabilities. This mobile scanner is crucial for enhancing diagnostic imaging services while adhering to regulatory standards and medical imaging protocols. Interested vendors must submit their company details and descriptive literature by March 14, 2025, and should be registered in the System for Award Management (SAM) to be eligible for future contract opportunities. For further inquiries, vendors can contact Contracting Officer Stacy Massey at Stacy.Massey@va.gov or by phone at 414-844-8400.
    6505--Fludrocortisone Acetate Tablets (VA-25-00047932)
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for Fludrocortisone Acetate 0.1MG Tablets, packaged in bottles of 100 tablets, to ensure a reliable supply for various federal entities, including the Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The procurement aims to award a single contract that covers an initial term of one year, with the option for four additional one-year periods, thereby securing an uninterrupted source of this essential medication. The estimated annual requirement for the tablets is 31,127 bottles, and interested suppliers must provide a unique NDC or UPC number along with the product name as it appears on the label. The solicitation is expected to be published on or around March 28, 2025, with proposals due by April 11, 2025; inquiries can be directed to Youlanda Duggar at Youlanda.Duggar@va.gov or by phone at 708-786-4943.
    6509--Solifenacin Tabletes (VA-25-00037090)
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Solifenacin Tablets, designated as RFP 36E79725R0020. This procurement aims to establish a reliable supply of Solifenacin for the VA, Department of Defense (DoD), and other federal health agencies, with the contract expected to last one year and include four optional renewal periods. Solifenacin is a critical medication used in the treatment of overactive bladder, highlighting the VA's commitment to ensuring access to essential pharmaceuticals for veterans and associated healthcare providers. Interested vendors should monitor SAM.gov for the RFP release, anticipated around March 14, 2025, with proposals due by March 28, 2025; for further inquiries, they may contact Contract Specialist Kenneth Lay at Kenneth.Lay@va.gov or by phone at 708-786-4879.
    6505--Aprepitant Capsules
    Buyer not available
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0029 concerning the procurement of Aprepitant Capsules, aimed at ensuring a continuous supply for various federal entities, including the Department of Defense and the Bureau of Prisons. Offerors are required to provide a unique National Drug Code (NDC) number and ensure that their label is the sole representation on the product, with the contract set for one year plus four optional annual extensions. This procurement is critical for serving veterans and other federal health care facilities, with substantial estimated annual requirements for Aprepitant in various dosages. Interested parties should note that the solicitation will be released around March 25, 2025, with a closing date of April 8, 2025, and are encouraged to contact Matthew Poulin at matthew.poulin@va.gov for inquiries.
    6525--DEC 2024 Equipment Only Consolidation
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the procurement of medical equipment under the solicitation titled "6525--DEC 2024 Equipment Only Consolidation." This initiative aims to acquire advanced imaging equipment, specifically focusing on high-tech medical devices for the National Acquisition Center, with an emphasis on compliance with updated technical specifications and training requirements for clinical staff. The equipment is crucial for enhancing healthcare services provided to veterans, ensuring improved diagnostic capabilities and operational efficiency within VA facilities. Interested vendors must submit their proposals by April 9, 2025, and direct any inquiries to Contract Specialist Hermann A Degbegni at hermann.degbegni@va.gov.
    6640--Electrophoresis Testing for Albany, Buffalo, and Syracuse VA Medical Centers.
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for electrophoresis testing services at the Albany, Buffalo, and Syracuse VA Medical Centers. This procurement aims to fulfill a critical need for laboratory services, specifically for tests such as Serum Protein Electrophoresis (SPEP), Urine Protein Electrophoresis (UPEP), Immuno-Fixation Electrophoresis (IFE), and Cerebral Spinal Fluid (CSF)/Oligoclonal testing, which are essential for supporting veteran healthcare. The contract will be structured as an Indefinite Delivery, Indefinite Quantity (IDIQ) arrangement, with an estimated annual requirement of 4,836 tests, and is set to commence on April 1, 2025, lasting until March 31, 2030. Interested vendors must submit their proposals by March 18, 2025, at 4:00 PM Eastern Standard Time, and can direct inquiries to Contracting Officer Jonathan Kilgore at jonathan.kilgore@va.gov or by phone at 973-676-1000.
    DA10--Medicom Imagex Service Contract *BRAND NAME ONLY*
    Buyer not available
    The Department of Veterans Affairs (VA) is seeking qualified vendors to provide a Medicom Imagex Service Contract aimed at enhancing the electronic exchange of radiology imaging exams and reports for veterans seeking diagnostic services outside the VA, particularly under the Mission Act. The contract will focus on automating the transfer of medical images to reduce delays caused by physical media like CD-ROMs, while ensuring integration with existing VA technologies to facilitate bi-directional data exchange with community healthcare providers. This initiative is critical for improving the continuity of care for veterans and minimizing operational bottlenecks in accessing diagnostic imaging. Interested parties, especially service-disabled veteran-owned and small businesses, are encouraged to respond to this Sources Sought Notice for market research purposes, with further details available from Contracting Specialist Matt Lee at matthew.lee5@va.gov or 210-939-9281.
    6505--Insulin (VA-25-00026482)
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of insulin and its derivatives under the solicitation titled "6505--Insulin (VA-25-00026482)." This procurement aims to establish a reliable supply source for pharmaceutical products, specifically focusing on competitive pricing for a base year plus four option years, while ensuring compliance with the Drug Supply Chain Security Act (DSCSA) and good manufacturing practices (cGMP). The contract is critical for maintaining quality healthcare for government participants, and interested offerors must submit their proposals by March 14, 2025, at 2:30 PM Central Standard Time, with all submissions including a 0.5% Cost Recovery Fee. For further inquiries, potential contractors can contact Contract Specialist Billy Fong at Billy.Fong@va.gov.